FDA approves AstraZeneca’s Saphnelo for SLE

SLE is an autoimmune condition causing symptoms such as joint swelling, rashes, and organ damage. Credit: StanislavSukhin / Shutterstock.com.



  • FDA AstraZeneca Saphnelo